发明名称 |
Use of Interleukin-27 as a Diagnostic Biomarker for Bacterial Infection in Critically Ill Patients |
摘要 |
Embodiments of the invention are directed to methods of diagnosing bacterial infection in a critically ill patient. The methods include obtaining a sample from the patient and determining the patient's level of IL-27 expression. Embodiments of the invention are also directed to methods that include determining both the patient's levels of IL-27 expression and PCT expression and using the combined result to provide a diagnosis of bacterial infection in a critically ill patient. |
申请公布号 |
US2015233942(A1) |
申请公布日期 |
2015.08.20 |
申请号 |
US201314424919 |
申请日期 |
2013.08.30 |
申请人 |
Children's Hospital Medical Center |
发明人 |
Wong Hector R. |
分类号 |
G01N33/68;G01N33/74 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for differentiating between sterile inflammation and bacterial infection in critically ill patients with fever and other signs of the systemic inflammatory response syndrome (SIRS) with high specificity and a high positive predictive value, comprising:
obtaining a serum sample from a critically ill patient (meeting criteria for SIRS or sepsis); measuring serum IL-27 protein concentration in said sample; treating said patient for bacterial infection where the serum IL-27 protein concentration is 5 ng/ml or higher. |
地址 |
Cincinnati OH US |